Member Info for Kingping25

Anyday now announcement I believe and pediatrics to start. Gonna be on a roll and this is gonna fly

Any day this is gonna re rate all the way up to £13 over a period of 2 months as treatment is officially started again. If your on the fence, it will be too late to lock in these prices in a weeks time.

I’m expecting this news end of next week. Exciting times

Down 20% in last 2 weeks - love it haha

Once we inject again and this is imminent as well as pediatrics this is gonna go nuts and a frenzy will start this will be north of £12 very shortly. You have limited days to buy at these prices. It’s not a case of if just when. There is not many shares at these prices as the bulk are much much higher.

Https://www.mdanderson.org/patients-family/diagnosis-treatment/clinical-trials/clinical-trials-index/clinical-trials-detail.ID2024-1178.html

You really do talk nonsense sometimes ald, I own about 1.6% of this company and between mr India, haywain, h4h, and many others I’m in touch with in addition to the shares of David smith, Vlad, Alexis and the new placee this represents 35% roughly of all holdings. There is not many shares out there in volume to buy.

Main lth are not selling and when the market wants these shares again as they will upon trial news this will go bonkers like it did before. This drop represents a few selling - look at the volume and please stop talking fud.

Trials are underway and we are funded for up to a yr. the downsize atm in my opinion is low. We have so much to be excited by and Hemo is in best position. It’s been in for 5 yrs.

P4 injection

Pediatric 1 injection - this will be big

Celin tech transfer updates

Cdx news

Update on progress of p1 - could be massive

We are funded and in short term this is surely bullish

Oct was last time this was over £12

What a gift at this price

Could be treating p4 potentially tomo onwards and rns from next week. Load up people. Ride is about restart

So if avacta is so great, why would you be on a hemogenyx group chat promoting it and not on the avacta group. I’m a little confused here. Why would you bother investing in hemogenyx and not put all your funds in avacta

The company will be injecting patients soon enough. Recruitment has started and when this gets momentum these prices now are laughable. Top up fellow Hemo lth,s. I am!!

Be brave when others fearful. (Opportunity!!)

I’ve had confirmation there is no wait period, this is systems all go. Company has never been in this situation:-

No money issues and huge run way

Patients being recruited

News on other products

These prices will be distant memory in a month or two when it re rates

I’m new here. I bought £11.5k worth at 3p.

Can someone educate me here, how much run way has the company got following the atm placing which they draw down money only last month up to their limit nearly?

I’m convienced tech transfer will be complete and injections on another patient by this period and so will be in excess of £18 per share

On record king ping

50% re rate any day

FDA sign off and recruitment.

Cdx and Estonia news due anytime as well.

Wait is painful but due and best of luck to all that held

Last patient was treated in Aug 25. They would have instigated the tech transfer at this time. I heard whispers that 2nd test run was in play in Nov, meaning 1 was in Oct, 2 in Nov and 3 in dec. to be conservative the report to the fda would of been done end of dec to mid Jan and this takes 30 days. Therefore I would expect news this week ref tech transfer complete (Vlad said final stages) and recruitment for p4 and pediatric 1. Been a long wait but production can now be cheaper and faster. More patients, more data and higher value for share holders.

Good luck everyone.

This is about to re rate. See charts and news pending.

Very exciting

Under the new protacol, the adults now only need 14 days in between the higher dose and pediatrics are the old rules of the lower dose and 30 days. This will mean that over a 6 month period being conservative you could expect, 5/6 adults treated and 3/4 children. Each new piece of data makes the company more valuable and a take over target where big pharma are actively and aggressively buying car t programmes.

In addition you have cdx which has been validated to a certain degree by the trials as the car-t came out of this platform and the cbr platform which has bigger potential than the mind can imagine and can merge with developing AI programmes out there.